Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the drug ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...

Without proper disposal practices, used sharps can pose a serious risk.

Charlie Evans, 13, who suffers from severe food allergies and eosinophilic esophagitis (EoE), takes part in an NIH-funded study at Cincinnati Children's hospital. The NIH dismissed the hospital's ...

Cassidy was an updates editor whose main responsibility is to write and edit articles on a range of home improvement topics. Her passion for lifestyle writing began with her editorial apprenticeship ...

PODS pioneered portable moving and storage in 1998, offering a simpler and more flexible way to move for more than 25 years. Today, with over seven million moves, PODS provides residential and ...